The efficacy and safety of the addition of programmed cell death protein 1 inhibitor to preoperative chemotherapy in locoregionally advanced oropharyngeal carcinoma
The incorporation of a PD-1 inhibitor into preoperative chemotherapy may be an effective approach for treating LAOPC and involve acceptable toxicity.
Authors
- Limei Guan
- Guanzhong Lu (ORCID: https://orcid.org/0000-0003-2031-785X)
- San‐Gang Wu (ORCID: https://orcid.org/0000-0002-0556-2614)
- Lin-Feng Guo (ORCID: https://orcid.org/0009-0008-6696-8096)
- Zhicong Hong
- Daniel Thomas Ginat (ORCID: https://orcid.org/0000-0003-3301-4364)
- Yifeng Yu (ORCID: https://orcid.org/0000-0002-6598-2274)
Institutions
- University of Chicago (US)
- First Affiliated Hospital of Xiamen University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.21037/tcr-2025-202
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05